KKR opens take-private bid for France's Albioma

Albioma’s first solar power plant with integrated storage has been installed on the roof of a shopping centre in Saint-Pierre, on Reunion Island. All rights reserved.

June 24 (Renewables Now) - US buyout firm KKR & Co Inc (NYSE:KKR) has launched its board-recommended tender offer for all shares and warrants of French independent renewable energy producer Albioma SA (EPA:ABIO).

KKR’s proposal of EUR 50.00 (USD 52.6m) per share, excluding a cash dividend of EUR 0.84, is a premium of 51.6% over Albioma's undisturbed share price on March 7, prior to the start of market rumours. The offer price for warrants (BSAARs) is EUR 29.10 apiece.

The tender bid was deemed compliant by the Autorite des marches financiers (AMF) on June 21. The completion of the transaction is subject to KKR securing a stake of at least 50.01% in Albioma and is also conditional upon approval by the European Commission.

The buyout firm has said it intends to delist the French company should it obtains an ownership interest of at least 90% through the tender offer.

It has been announced that Albioma’s shareholder since 2016 – Bpifrance – will invest alongside KKR, while others such as Compagnie Financiere Europeenne de Prises de Participation (COFEPP), CDC Croissance and Norges Bank have committed to tender their existing shareholdings.

Albioma owns and operates biomass and solar power plants in both metropolitan and overseas France, Mauritius and Brazil, as well as geothermal energy production facilities in Turkey. Its total installed capacity exceeds 1 GW.

(EUR 1.0 = USD 1.052)

Join Renewables Now's free daily newsletter now!

More stories to explore
Share this story
About the author
Browse all articles from Ivan Shumkov

Ivan is the mergers and acquisitions expert in Renewables Now with a passion for big deals and ambitious capacity plans.

More articles by the author
5 / 5 free articles left this month
Get 5 more for free Sign up for Basic subscription
Get full access Sign up for Premium subscription